✦ LIBER ✦

Double-blind clinical trials of proteolytic enzyme therapy in oral surgery

✍ Scribed by Forrest, W.I.N. ;Goodridge, D.L. ;MacDonald Watson, A. ;Starkey, W.E.

Book ID: 114005789
Publisher: Elsevier Science
Year: 1968
Tongue: English
Weight: 209 KB
Volume: 6
Category: Article
ISSN: 0266-4356
DOI: 10.1016/s0007-117x(68)80021-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral preoperative antioxidants in pancre

Oral preoperative antioxidants in pancreatic surgery: A double-blind, randomized, clinical trial

✍ Marco Braga; Massimiliano Bissolati; Simona Rocchetti; Aldo Beneduce; Nicolò Pec 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 359 KB

P329 ORAL PREOPERATIVE ADMINISTRATION OF

P329 ORAL PREOPERATIVE ADMINISTRATION OF ANTIOXIDANTS IN PANCREATIC SURGERY: A DOUBLE-BLIND, RANDOMIZED CLINICAL TRIAL

✍ M. Bissolati; S.I. Rocchetti; A.A. Beneduce; N. Pecorelli; M. Braga 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Levosimendan in Congenital Cardiac Surge

Levosimendan in Congenital Cardiac Surgery: A Randomized, Double-Blind Clinical Trial

✍ Mona Momeni; Jean Rubay; Amine Matta; Marie-Thérèse Rennotte; Francis Veyckemans 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 368 KB

The blind spot in the nicotine replaceme

The blind spot in the nicotine replacement therapy literature: Assessment of the double-blind in clinical trials

✍ Marc Mooney; Thom White; Dorothy Hatsukami 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Double-blind assessment of therapeutic e

Double-blind assessment of therapeutic efficacy in clinical trials

✍ Sidney Cohen 📂 Article 📅 1983 🏛 Springer US 🌐 English ⚖ 144 KB

Topical bleomycin treatment of oral leuk

Topical bleomycin treatment of oral leukoplakia: A randomized double-blind clinical trial

✍ Joel B. Epstein; Frances L. W. Wong; Amelia Millner; Nhu D. Le 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 570 KB

## Abstract __Background.__ Oral leukoplakia and oral erythroplakia may be associated with benign and dysplastic cellular changes, and are at risk of malignant transformation. Additional means of management of these lesions is needed. The results of nonblinded trials using topical bleomycin in oral